Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q2 2013 · 10-Q
Revenue—
Net Income$9.00K$9.00KN/M vs Q2 2012 EPS Diluted$0.00$0.00— vs Q2 2012 Gross Profit$69,000+305.9% Operating Income$6,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Operating Cash Flowderived$15,000N/M ended Jun 30, 2013 · filed Jul 26, 2013 · 26 d after period end